Inventor · disambiguated record
William Lubell
Also filed as: LUBELL WILLIAM · LUBELL WILLIAM D
12 granted patents·8 pending applications·161 citations·filing 2002–2021
88Inventor score
Files withVALORISATION-RECHERCHE LTD PARTNERSHIP3UNIV MONTREAL2BIOAXONE THERAPEUTIQUE INC1CHEMTOB SYLVAIN1CHU SAINTE JUSTINE1
Top patents by PatentIndex Score
20 records- 0193US7572913B24-substituted piperidine derivativesBIOAXONE THERAPEUTIQUE INC·Filed 2005·Granted Aug 11, 2009·129 cites·19 claims
- 0281US7521530B2Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin F2α receptorUNIV MONTREAL·Filed 2002·Granted Apr 21, 2009·17 cites·6 claims
- 0376US8618054B2Interleukin-1 receptor antagonists, compositions, and methods of treatmentCHEMTOB SYLVAIN·Filed 2005·Granted Dec 31, 2013·7 cites·16 claims
- 0474US9115171B2Azapeptides as CD36 binding compoundsVALORISATION RECHERCHE LTD PARTNERSHIP·Filed 2013·Granted Aug 25, 2015·3 cites·14 claims
- 0569US8614233B2Cinnamoyl inhibitors of transglutaminasePARDIN CHRISTOPHE·Filed 2008·Granted Dec 24, 2013·3 cites·3 claims
- 0666US2010041609A1Interleukin-1 receptor antagonists, compositions, and methods of treatmentVALORISATION RECH SOC EN COMMA·Filed 2009·Application pending·0 cites
- 0765US8435954B2Azapeptides as CD36 binding compoundsONG HUY·Filed 2008·Granted May 7, 2013·1 cites·2 claims
- 0861US8993515B2Peptidomimetics comprising N-amino cyclic urea residues and uses thereofVALORISATION RECHERCHE LTD PARTNERSHIP·Filed 2013·Granted Mar 31, 2015·1 cites·19 claims
- 0956US9073963B2Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin F2α receptorPERI KRISHNA·Filed 2009·Granted Jul 7, 2015·0 cites·11 claims
- 1055US9162991B2Cinnamoyl inhibitors of transglutaminaseUNIV OTTAWA·Filed 2013·Granted Oct 20, 2015·0 cites·4 claims
- 1155US2021322509A1Methods for Reducing Perinatal Morbidity and / or MortalityOLSON DAVID·Filed 2021·Application pending·0 cites
- 1253US2024247029A1Interleukin-1 receptor modulators and uses thereofVALORISATION HSJ LP·Filed 2021·Application pending·0 cites
- 1346US2010190710A1Il-23 receptor antagonists and uses thereofVALORISATION HSJ SOC EN COMMAN·Filed 2008·Application pending·0 cites
- 1445US2024316225A1Synthetic cyclic peptide mimeticsUNIV BAR ILAN·Filed 2021·Application pending·0 cites
- 1544US9708370B2Azapeptides as CD36 binding compoundsVALORISATION-RECHERCHE LTD PARTNERSHIP·Filed 2015·Granted Jul 18, 2017·0 cites·20 claims
- 1641US8802818B2Prostaglandin-F2 alpha receptor modulators and uses thereofLUBELL WILLIAM D·Filed 2012·Granted Aug 12, 2014·0 cites·7 claims
- 1741US2004138272A11,4-Substituted cyclohexane derivativesFiled 2003·Application pending·0 cites
- 1841US2019091279A1Methods for reducing perinatal morbidity and/or mortalityCHU SAINTE JUSTINE·Filed 2016·Application pending·0 cites
- 1940US11879021B2Cyclic peptides and uses thereofUNIV MONTREAL·Filed 2017·Granted Jan 23, 2024·0 cites·15 claims
- 2028US2012101257A1Processes for preparing amino-substituted gamma-lactamsLUBELL WILLIAM·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when William Lubell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →